Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective
Arun Kadamkulam Syriac, Nitish Singh Nandu, José Pablo Leone
Breast Cancer Targets and Therapy (2022) Vol. Volume 14, pp. 1-13
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
Sara A. Hurvitz, Aditya Bardia, Kevin Punie, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
Mariia Ivanova, Francesca Porta, Federica Giugliano, et al.
Genes (2023) Vol. 14, Iss. 6, pp. 1160-1160
Open Access | Times Cited: 19
9S1R nullomer peptide induces mitochondrial pathology, metabolic suppression, and enhanced immune cell infiltration, in triple-negative breast cancer mouse model
Nilufar Ali, Cody Wolf, Swarna Kanchan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115997-115997
Open Access | Times Cited: 12
Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature review
Volkmar Müller, Rupert Bartsch, Nancy U. Lin, et al.
Cancer Treatment Reviews (2023) Vol. 115, pp. 102527-102527
Closed Access | Times Cited: 11
Targeting fatty acid synthase in preclinical models of TNBC brain metastases synergizes with SN-38 and impairs invasion
Habib Serhan, Liwei Bao, Cheng Xu, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Onco-immunity and therapeutic application of amygdalin: A review
Ahmed Mohammed Alwan, Dinesh Rokaya, Goma Kathayat, et al.
Journal of Oral Biology and Craniofacial Research (2022) Vol. 13, Iss. 2, pp. 155-163
Open Access | Times Cited: 19
Radiotherapy and Radiosurgery for Intracranial Lesions in Africa: Insights from Three Country Case Studies – A Systematic Review
Ishav Shukla, Jason Wang, Mina Guirguis, et al.
Neuro-Oncology Advances (2025) Vol. 7, Iss. 1
Open Access
Breast Cancer‐Derived Extracellular Vesicles Modulate the Cytoplasmic and Cytoskeletal Dynamics of Blood‐Brain Barrier Endothelial Cells
Sara Busatto, Tzu‐Hsi Song, Hyung Joon Kim, et al.
Journal of Extracellular Vesicles (2025) Vol. 14, Iss. 1
Open Access
Extracellular vesicles in triple-negative breast cancer: current updates, challenges and future prospects
Prashant Tiwari, Anis Ahmad Chaudhary, Saurabh Gupta, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Novel TROP2 antibody–drug conjugates for treatment of HER2-negative metastatic breast cancer patients with brain metastases: a promising option☆
Jian Wang, Yi Zhang, Rilan Bai, et al.
ESMO Open (2025) Vol. 10, Iss. 5, pp. 105059-105059
Open Access
Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53
Lauren Scarpetti, Chetan C. Oturkar, Dejan Juric, et al.
The Oncologist (2023) Vol. 28, Iss. 4, pp. 358-363
Open Access | Times Cited: 9
BCRP drives intrinsic chemoresistance in chemotherapy-naïve breast cancer brain metastasis
Rebeca Uceda-Castro, Andreia S. Margarido, Ji‐Ying Song, et al.
Science Advances (2023) Vol. 9, Iss. 42
Open Access | Times Cited: 9
Single‐cell sequencing reveals the immune landscape of breast cancer patients with brain metastasis
H. Zhou, Xiang He, Jia Huang, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 9, pp. 702-714
Open Access | Times Cited: 3
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation
Dušan Ružić, Bernhard Ellinger, Nemanja Djoković, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2600-2600
Open Access | Times Cited: 14
Epithelial-to-Mesenchymal Transition Drives Invasiveness of Breast Cancer Brain Metastases
Andreia S. Margarido, Rebeca Uceda-Castro, Kerstin Hahn, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3115-3115
Open Access | Times Cited: 13
An Insight into Molecular Targets of Breast Cancer Brain Metastasis
Mohammed Kaleem, Mahmood Hassan Dalhat, Lubna Azmi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11687-11687
Open Access | Times Cited: 12
Blood-tumor barrier opening by MRI-guided transcranial focused ultrasound in a preclinical breast cancer brain metastasis model improves efficacy of combinatorial chemotherapy
Tasneem Arsiwala, Kathryn E. Blethen, Cullen P. Wolford, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Brain endothelial cells promote breast cancer cell extravasation to the brain via EGFR-DOCK4-RAC1 signalling
Chiara Galloni, Teklu Egnuni, Safoura Zahed Mohajerani, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview
Rupesh Kotecha, Alonso La Rosa, Paul D. Brown, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 2
Is antibody-drug conjugate a rising star for clinical treatment of solid tumors? A systematic review and meta-analysis
Leyin Zhang, Deyi Shen, Lulin Yu, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 177, pp. 103758-103758
Closed Access | Times Cited: 11
Overcoming challenges to enable targeting of metastatic breast cancer tumour microenvironment with nano-therapeutics: Current status and future perspectives
Karishma Niveria, Monika Yadav, Kapil Dangi, et al.
OpenNano (2022) Vol. 8, pp. 100083-100083
Open Access | Times Cited: 11
Cost-effectiveness of sacituzumab govitecan versus chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer
Jiao Xie, Sini Li, Yamin Li, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Brain metastasis screening in the molecular age
Joanna K. Tabor, Amanda Onoichenco, Vinayak Narayan, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 5
Altered Mental Status in Cancer
John Y. Rhee, Vihang Nakhate, Christy Soares, et al.
Seminars in Neurology (2024) Vol. 44, Iss. 06, pp. 652-669
Closed Access | Times Cited: 1
Sacituzumab govitecan response in extensive leptomeningeal carcinomatosis from triple-negative breast cancer: a case report
J. Yaringaño, María Roca-Herrera, Simeón Eremiev, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top